ROSENWALD LINDSAY A MD 4
4 · Fortress Biotech, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
ROSENWALD LINDSAY A MD
DirectorPRESIDENT, CEO & CHAIRMAN10% Owner
Transactions
- Award
Common stock, par value $0.001
2025-01-01+454,153→ 4,111,417 total
Footnotes (1)
- [F1]The Reporting Person was granted 454,153 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2025.